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ABSTRACT
The MAPU 2.0 database contains proteomes of
organelles, tissues and cell types measured by
mass spectrometry (MS)-based proteomics. In con-
trast to other databases it is meant to contain a
limited number of experiments and only those with
very high-resolution and -accuracy data. MAPU 2.0
displays the proteomes of organelles, tissues and
body fluids or conversely displays the occurrence
of proteins of interest in all these proteomes.
The new release addresses MS-specific problems
including ambiguous peptide-to-protein assign-
ments and it provides insight into general functional
features on the protein level ranging from gene
ontology classification to comprehensive SwissProt
annotation. Moreover, the derived proteomic data
are used to annotate the genomes using Distributed
Annotation Service (DAS) via EnsEMBL services.
MAPU 2.0 is a model for a database specifically
designed for high-accuracy proteomics and a
member of the ProteomExchange Consortium. It is
available on line at http://www.mapuproteome.com.
INTRODUCTION
Mass spectrometry (MS)-based proteomics has progressed
dramatically in throughput, accuracy and sensitivity and
this trend shows no sign of abating (1,2). In order to make
the data useful to the larger biomedical community, they
have to be easily accessible via the web. Existing proteome
databases have focused on diﬀerent aspects of proteomic
data capture and data mining. The PRIDE database, for
example, was primarily developed as a vehicle to share
proteomic experiments (3). The PeptideAtlas project, on
the other hand, is mainly interested in collecting data on
peptide fragmentation patterns as a tool for improving
future proteomics experiments (4,5). In a similar vein,
the Global Proteome Machine Database (GPMDB), col-
lects tandem mass spectra with a view to improve peptide
identiﬁcation (6,7). These and other proteome databases
are beginning to be connected in the ProteomExchange
Consortium (8).
In contrast to the above eﬀorts, our group has focused
on the development of a proteome database speciﬁcally
for very high-resolution and high-accuracy data. Such
data could previously only be generated by a few specia-
lized laboratories but the required instrumentation has
now spread to hundreds of sites. By only admitting
high-resolution data, we avoid a problem endemic to data-
bases that aggregate a wide variety of heterogeneous data,
namely the control of overall false positive rates for pro-
tein identiﬁcation.
The Max-Planck Uniﬁed (MAPU) proteome database
contains data from large-scale projects on the mapping of
body ﬂuids, tissues and cell lines (9). Its new version,
MAPU 2.0, provides a comprehensive proteome informa-
tion system consisting of the data integration of combined
large-scale proteomic projects and the inclusion of protein
annotations from standard protein databases, such as
UniProt (10). To allow the peptide-based retrieval of
high-accuracy proteomic data across projects in a scalable
way, we changed the basic concept of the MAPU database
completely. The main modiﬁcations are the combination
of various proteomic sub-databases, of a modern pro-
gramming environment (C# and .NET) allowing a rich
graphical user experience, solving MS speciﬁc problems
such as peptide-to-protein assignments, the inclusion of
additional large-scale proteomic datasets, the detailed
cross-reference to SwissProt annotations and two-way
connection to EnsEMBL using Distributed Annotation
Service (DAS) technology.
The last point is speciﬁcally pertinent, because as the
number of sequenced genomes increases rapidly (11), the
annotation of these sequences with biological information
becomes increasingly important. Mapping large-scale
data derived from MS-based proteomics to the genome
sequence is one valuable annotation because it veriﬁes
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EnsEMBL project provides an excellent system to inte-
grate any kind of data that contributes to the annotation
of the genome (12,13). In MAPU 2.0, we map high-accu-
racy proteomic data to the genome in a two way fashion
and used the DAS source system to illustrate certain fea-
tures including the presence of the protein in speciﬁc cell
types for each identiﬁed gene transcript.
METHODS AND MATERIALS
General conceptof MAPU 2.0
The initial content and format of MAPU have been
described in Zhang et al. (9). The basic schema of the
database has changed dramatically, and the new database
version uniﬁes all sub-databases by reassigning the mea-
sured peptides along with their corresponding data from
each experiment to protein entries of an updated database
version. The new architecture is based in part on concepts
developed for the Phosphorylation Site Database
[PHOSIDA; www.phosida.com (14,15)]. It allows the
organism-speciﬁc retrieval of various cell-type and organ-
elle associated proteomic data. The user can query the
database organism-speciﬁcally by protein name, protein
description, gene symbol, accession of the database used
for identiﬁcation [such as the International Protein Index
(IPI) (16)], SwissProt accession identiﬁer, protein sequence
or peptide sequence (Figure 1, left panel). If more than
one protein entry matches with the submitted query string,
MAPU 2.0 will list all relevant proteins and mark the ones
identiﬁed in at least one proteomic experiment, in red
(Figure 1, middle panel). Clicking on one of the red high-
lighted entries leads to the result page (Figure 1, right
panel). If there is just a single match to the query, the
web user will be guided directly to the result page describ-
ing the inquired protein. The left panel of the resulting
web page displays investigated cell types and tissues. If
the protein was detected in a certain sub-proteome,
the corresponding button is highlighted (Figure 1, right
panel). Otherwise, the image of the tissue or cell type is
illustrated in light colors indicating the absence of the
speciﬁed protein of interest. Clicking on one of the buttons
on the left panel results in the complete listing of all pep-
tides that have been measured in the selected cell type
along with associated data such as peptide identiﬁcation
scores or identiﬁcation scores for post-translational mod-
iﬁcations (PTMs) (Figure 2).
The peptide-to-protein assignment presents one of the
main problems in ‘shotgun’ MS, where proteins are ﬁrst
digested to peptides, since a given peptide might occur in
several proteins (17). Multiple incidences of a certain pep-
tide sequence can cause ambiguous protein assignments. In
accordance with Occam’s razor, we assign a given peptide
sequence to the candidate protein with the highest number
of peptides within one project. The user is alerted to this
problem by color highlighting the listed peptides: green
indicates that the selected protein of interest has the max-
imum number of peptides in comparison to all other pro-
teins that contain the same peptide, whereas blue indicates
that there is another protein entry that contains the peptide
and shows the same number of identiﬁed peptides in total.
Red points to the occurrence of another protein, which
shows a higher number of detected peptides in total and
thus presents the more likely associated protein. When
pointing the mouse to one of the corresponding ‘occur-
rences’ buttons, a blue colored pop-up box lists all protein
entries that contain the given peptide along with the total
number of containing peptides that have been identiﬁed
(Figure 2). If the experimental design included the organel-
lar localizations of proteins, all organelles in which the
protein of interest was detected are listed.
In addition to the illustration of associated cell types
and organelles along with the measured peptides, general
Figure 1. To retrieve proteomic data for a protein of interest, one can search organism speciﬁcally via accession number, gene symbol, protein
description, protein name or peptide sequence (left panel). If there are several hits for a query, all potential proteins of interest are listed (middle
panel). Proteins that have been identiﬁed in any of the projects in MAPU 2.0 are shown in red. The ﬁnal result page provides a total overview of cell
types and tissues that contain the protein of interest (right panel).
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descriptions and full protein sequences, the corresponding
Gene Ontology identiﬁers (18) are listed linking to the
Gene Ontology web site reporting full descriptions of
the selected annotation. Furthermore, the annotations to
each instance include PubMed references and general fea-
tures such as active sites, motifs, domains or signaling sites
derived from SwissProt (Figure 3). Since there may be
several isoform entries corresponding to one SwissProt
entry, we BLASTP-aligned the protein sequence of each
SwissProt instance with that of the corresponding entry of
the database used for matching the spectra to peptide
sequence (usually the IPI). The main purpose of this exten-
sive alignment approach is to derive the exact sequence
positions of relevant protein features that are annotated
in SwissProt within the protein sequences of the entry of
the database used for MS identiﬁcation.
Proteomics datasets containing quantitative informa-
tion in the form of isotope ratios are becoming the norm
rather than the exception (19). In this case, the median
quantitative data of all measured and assigned peptides
is taken to quantify the protein.
Additionally, each displayed web page includes a ques-
tion mark button that directs to the help section of MAPU
2.0 describing the format of the current page or exempli-
fying the web application guideline. These help sections
are also available via the ‘background’ section of
MAPU 2.0, which also contains general descriptions of
the experimental designs of various projects.
To allow the retrieval of legacy sub-databases that
could not be included in the new concept, a link to the
old database version is provided. This is the case for the
organellar database (20) as well as the red blood cell data-
base (21), as both datasets are exclusively protein-based
and therefore cannot be mapped to MAPU 2.0 due to the
lack of peptide information.
MAPU 2.0 is based on a modern and scalable software
architecture, namely C# and the ASP.NET technology.
This allows MAPU 2.0 to share class libraries, with
PHOSIDA (15). The concepts and web applications of
MAPU 2.0 and PHOSIDA are very similar and show
that very distinct proteomic databases can be built using
shared components.
Genome Annotation
We spent particular eﬀorts on precisely mapping our high-
resolution proteomic data to the genome. For this pur-
pose, we extracted measured peptides of each proteomic
dataset and reassigned the peptide sequences to genes
annotated in the EnsEMBL database (11). If a speciﬁed
peptide matches with sequences of more than one trans-
lated gene, we assigned the peptide to the gene transcript
that shows the highest number of matching peptides
in total within the associated project. Therefore, the
peptide-to-gene transcript assignment results one-to-one
relationships reducing potential redundancy.
Figure 3. For each protein that has a SwissProt accession number,
general features such as active sites, domains and motifs are displayed
and mapped to the entry of the database that was used for
identiﬁcation.
Figure 2. For each project, all measured peptides are listed along with
validation scores such as the Mascot protein identiﬁcation score.
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‘notepad’ button located next to the main ‘web book’ of
MAPU 2.0 (Figure 4). The user ﬁrst selects a species of
interest. The karyotype of the selected species is illustrated
along with a link that connects to the EnsEMBL genome
annotation webpage. Clicking of the displayed chromo-
somes generates a more detailed image of the chosen
chromosome along with general information including
chromosome length, number of known and predicted
genes, quantity of occurring single nucleotide polymorph-
isms (SNPs) and number of gene transcripts. Besides these
annotations, which are derived from the EnsEMBL data-
base, the number of gene transcripts that have been iden-
tiﬁed in MAPU 2.0 is indicated.
Furthermore, each chromosome is divided into 93 bins:
on the left hand side the number of transcripts annotated
in EnsEMBL is displayed. Selecting one of the bin boxes
pops up the EnsEMBL web page, showing a detailed view
of the selected chromosome region. On the right hand
side, the number of transcripts that have been detected
in any of the uploaded projects is illustrated for each
bin. Clicking on one of these bin buttons results in the
listing of all identiﬁed gene transcripts along with the
descriptions of the corresponding genes and exact locali-
zations on the chromosome. Moreover, a link is provided
for each gene transcript that connects to the EnsEMBL
homepage displaying the full annotation of that tran-
script. In addition to the general annotation of the given
gene transcript, the pop-up EnsEMBL page will show all
peptides that have been identiﬁed via the MAPU 2.0 DAS
source (12). Thus, whenever a web user requests the infor-
mation provided by MAPU 2.0 on EnsEMBL, the data
included in the MAPU 2.0 database are illustrated via the
DAS/Proserver system (13). Clicking on one of the illu-
strated peptides yields a report of all the cell types that
contain the peptides for this gene transcript. In addition to
the MAPU 2.0 DAS source, we have also established a
PHOSIDA DAS source providing all phosphorylation
sites that have been unambiguously identiﬁed (Class 1
sites) (14), but also phosphosites that lack precise identi-
ﬁcation within the phosphorylated peptide sequence due
to insuﬃcient fragment information in MS/MS (ambig-
uous sites).
SUMMARY AND PERSPECTIVES
MAPU 2.0 is a database speciﬁcally created for high-
resolution, high-accuracy proteomic data. It provides a
user-friendly environment and several of its concepts are
innovative and could be transferred to proteomic data-
bases of a more general nature. We addressed MS-speciﬁc
problems including ambiguous peptide-to-protein assign-
ments by straightforward approaches such as color high-
lighting of given peptide sequences. In addition, we used
the proteomic data that are integrated in MAPU 2.0 to
annotate the genome via the DAS technology provided by
the EnsEMBL project. MAPU 2.0 is becoming a member
Figure 4. The genome annotation section of MAPU 2.0 provides insight into the number of identiﬁed gene transcripts. It links each detected
transcript to the EnsEMBL database, which illustrates gene features derived from proteomic approaches via the MAPU 2.0 and PHOSIDA DAS
sources.
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be exchanged with other databases.
Mass spectrometric data is becoming much more accu-
rate and faster to produce, paralleling in some ways the
advent of next generation sequencing technology. This will
also bring particular opportunities and challenges. For
instance, we believe that proteomic data is now suﬃciently
readily produced in high quality, that it does not make
sense to store all proteomics results accompanying publi-
cations in central databases, particularly if the data was
generated in ‘one-oﬀ’ projects and with low resolution
technology. Instead, reference proteomes should be mea-
sured with extremely high-accuracy and in dedicated state
of the art facilities. We intend to further develop MAPU
with a view to serve as a model database for such high-
accuracy reference proteomes.
ACKNOWLEDGEMENT
We thank Andrew Jenkinson and Eugene Kulesha for
helping to establish the DAS system for MAPU 2.0,
Phani Garapati and Markus Fritz for testing the web
application and Michael Schuster for suggestions. We
also thank all of the users of our website and especially
those who have provided feedback.
FUNDING
Marie Curie Fellowship (to F.G.). Part of this work was
supported by ‘Interaction Proteome’ as 6th Framework
program by the EU directorate, which also funded for
open access charge.
Conﬂict of interest statement. None declared.
REFERENCES
1. Aebersold,R. and Mann,M. (2003) Mass spectrometry-based
proteomics. Nature, 422, 198–207.
2. Mann, M. and Kelleher, N.L. (2008) Precision proteomics:
the case for high resolution and high mass accuracy. PNAS,
doi:10.1073/pnas.0800788105.
3. Jones,P., Cote,R.G., Martens,L., Quinn,A.F., Taylor,C.F.,
Derache,W., Hermjakob,H. and Apweiler,R. (2006) PRIDE: a
public repository of protein and peptide identiﬁcations for the
proteomics community. Nucleic Acids Res., 34, D659–D663.
4. Desiere,F., Deutsch,E.W., King,N.L., Nesvizhskii,A.I., Mallick,P.,
Eng,J., Chen,S., Eddes,J., Loevenich,S.N. and Aebersold,R. (2006)
The PeptideAtlas project. Nucleic Acids Res., 34, D655–D658.
5. Deutsch,E.W., Lam,H. and Aebersold,R. (2008) PeptideAtlas: a
resource for target selection for emerging targeted proteomics
workﬂows. EMBO Rep., 9, 429–434.
6. Craig,R., Cortens,J.P. and Beavis,R.C. (2004) Open source system
for analyzing, validating, and storing protein identiﬁcation data.
J. Proteome Res., 3, 1234–1242.
7. Craig,R., Cortens,J.C., Fenyo,D. and Beavis,R.C. (2006) Using
annotated peptide mass spectrum libraries for protein identiﬁcation.
J. Proteome Res., 5, 1843–1849.
8. Hermjakob,H. and Apweiler,R. (2006) The Proteomics
Identiﬁcations Database (PRIDE) and the ProteomExchange
Consortium: making proteomics data accessible. Expert Rev.
Proteomics, 3, 1–3.
9. Zhang,Y., Zhang,Y., Adachi,J., Olsen,J.V., Shi,R., de Souza,G.,
Pasini,E., Foster,L.J., Macek,B., Zougman,A. et al. (2007)
MAPU: Max-Planck Uniﬁed database of organellar, cellular,
tissue and body ﬂuid proteomes. Nucleic Acids Res., 35,
D771–D779.
10. The UniProt Consortium (2008) The universal protein resource
(UniProt). Nucleic Acids Res., 36, D190–D195
11. Flicek,P., Aken,B.L., Beal,K., Ballester,B., Caccamo,M., Chen,Y.,
Clarke,L., Coates,G., Cunningham,F., Cutts,T. et al. (2008)
Ensembl 2008. Nucleic Acids Res., 36, D707–D714.
12. Dowell,R.D., Jokerst,R.M., Day,A., Eddy,S.R. and Stein,L. (2001)
The distributed annotation system. BMC Bioinformatics, 2,7 .
13. Finn,R.D., Stalker,J.W., Jackson,D.K., Kulesha,E., Clements,J. and
Pettett,R. (2007) ProServer: a simple, extensible Perl DAS server.
Bioinformatics, 23, 1568–1570.
14. Olsen,J.V., Blagoev,B., Gnad,F., Macek,B., Kumar,C.,
Mortensen,P. and Mann,M. (2006) Global, in vivo, and site-speciﬁc
phosphorylation dynamics in signaling networks. Cell, 127,
635–648.
15. Gnad,F., Ren,S., Cox,J., Olsen,J.V., Macek,B., Oroshi,M. and
Mann,M. (2007) PHOSIDA (phosphorylation site database): man-
agement, structural and evolutionary investigation, and prediction
of phosphosites. Genome Biol., 8, R250.
16. Kersey,P.J., Duarte,J., Williams,A., Karavidopoulou,Y., Birney,E.
and Apweiler,R. (2004) The International Protein Index: an inte-
grated database for proteomics experiments. Proteomics, 4,
1985–1988.
17. Nesvizhskii,A.I. and Aebersold,R. (2005) Interpretation of shotgun
proteomic data: the protein inference problem. Mol. Cell
Proteomics, 4, 1419–1440.
18. Ashburner,M., Ball,C.A., Blake,J.A., Botstein,D., Butler,H.,
Cherry,J.M., Davis,A.P., Dolinski,K., Dwight,S.S., Eppig,J.T. et al.
(2000) Gene ontology: tool for the uniﬁcation of biology.
Nat. Genet., 25, 25–29.
19. Ong,S.E. and Mann,M. (2005) Mass spectrometry-based
proteomics turns quantitative. Nat. Chem. Biol., 1, 252–262.
20. Foster,L.J., de Hoog,C.L., Zhang,Y., Xie,X., Mootha,V.K. and
Mann,M. (2006) A mammalian organelle map by protein
correlation proﬁling. Cell, 125, 187–199.
21. Pasini,E.M., Kirkegaard,M., Mortensen,P., Lutz,H.U.,
Thomas,A.W. and Mann,M. (2006) In-depth analysis of the
membrane and cytosolic proteome of red blood cells. Blood, 108,
791–801.
D906 Nucleic Acids Research, 2009, Vol. 37, Databaseissue